Deciphera Pharmaceuticals, Inc.·4

Jun 24, 4:05 PM ET

Allen Patricia L 4

4 · Deciphera Pharmaceuticals, Inc. · Filed Jun 24, 2022

Insider Transaction Report

Form 4
Period: 2022-06-23
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-23+18,50018,500 total
    Exercise: $13.98Exp: 2032-06-22Common Stock (18,500 underlying)
Footnotes (1)
  • [F1]This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 23, 2023, subject to continued service through such date.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT